AzTrials
AzTrials

Alcohol Use DisorderNCT06118346

A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings

A study testing Female-Specific Cognitive Behavioral Therapy (FS-CBT) in people with Alcohol Use Disorder and Risky Health Behavior, run by University of Massachusetts, Worcester at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Alcohol Use Disorder, Risky Health Behavior
What is being tested?
Female-Specific Cognitive Behavioral Therapy (FS-CBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
162 participants
Where
1 siteUnited States
Study dates
24 Feb 2023to 30 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • women aged 18 or older
  • Veteran of the U.S. Armed Forces
  • Enrolled in healthcare at VA NYHHS;
  • AUDIT-C ≥3 plus diagnosis of AUD and/or risky drinking (defined by the National Institute on Alcohol Abuse and Alcoholism as more than 3 drinks on any one day or more than 7 drinks per week) on more detailed screening
  • consumed alcohol within 90 days prior to our study's initial eligibility screen.

Who cannot join

  • participant is acutely suicidal
  • participant has acute psychotic or manic symptoms associated with severe mental illness
  • participant is pregnant at initial eligibility screen.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA New York Harbor Healthcare System

    New York, New York, 10010

Other trials in United States

About this study

Official title: A Female-Specific Cognitive Behavioral Therapy Group for Alcohol Use Disorder in VA Primary Care Settings

The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.

Read the detailed description

This is a five year Hybrid Type 1 effectiveness-implementation study. For Aim 1, 162 female Veterans with AUD will be enrolled over 2.5 years in the study at Primary Care and Women's Comprehensive Primary Care Clinics (i.e., the Women's Health Clinic) in the VA New York Harbor Healthcare System (VA NYHHS) (n=162) for a final sample of 140 at 15 month post-baseline (i.e.,12 month post treatment) follow up. The 86% follow up rate is based on Dr. Epstein's prior Randomized Control Trial (RCT) testing FS-CBT for civilian women with AUD on which the current Veteran- Centric FS-CBT group is based. After the research baseline interview, participants will be randomly assigned to either Usual Care (UC, which is Brief Alcohol Counseling +Referral to Substance Use Disorder (SUD) Specialty Care if indicated, all called Brief Alcohol Counselling (BAC), and otherwise also known as Brief Intervention and Referral to treatment (BIRT)) or to the 12 session, rolling entry group Veteran Female Specific CBT for AUD (FS-CBT) held within the VA NYHHS Women's Health Clinic. Participants in both conditions will complete the same baseline (BL), 3-, 9- and 15-months post-BL (i.e., 0-, 6-, \& 12-months after treatment) research assessments. Primary outcome variables will be treatment access (attending least one FS- CBT group session or 1 SUD specialty care session in the FS-CBT condition, and at least 1 SUD specialty care session in the usual UC condition; treatment engagement is defined as number of treatment hours attended in each condition); drinking outcomes (percent drinking days and percent heavy drinking days during and 1 year after the treatment phase). Secondary outcomes include drug use, mental health, social support for abstinence, and health behaviors. For Aim 2, a formative evaluation will be done during the RCT using program process data to track provider interest, patient enrollment rates, reasons for refusal, and treatment adherence.

Using an implementation science framework (Consolidated Framework for Implementation Research, CFIR), the investigators will evaluate implementation barriers and facilitators of FS-CBT in VA PC using qualitative interviews with 20 women Veterans in FS-CBT, 20 in UC, 15 women with AUD who were eligible but did not enroll in the RCT, and 16 providers/stakeholders. The goal of the formative evaluation is to help determine factors at the system, provider, and patient levels that affect the likelihood that FS-CBT will be successfully implemented and sustained in VA Primary Care (PC). The evaluation will allow for more rapid translational gains in terms of intervention uptake and sustainability. The evaluation will include the systematic collection of quantitative RCT process data (e.g., number and % of patient referral opt-outs by Primary Care Providers (PCPs), % of eligible women who enroll, reasons for refusal, number of group sessions completed by Veteran characteristics), and qualitative data via interviews with patient and staff stakeholders. To learn about patient-level barriers/facilitators, study personnel will conduct interviews with 20 female Veterans who were randomized to the FS-CBT condition, and 20 who were randomized to UC: (a) one-half will be drawn from those who completed the full dose (12 sessions in FS-CBT and all treatment recommendations in UC) and the other half from those who dropped out and completed less than the recommended minimal dose. Investigators will sample from participants who significantly reduced their drinking and from those who did not. Investigators will include a diverse sample of Veterans based on age, gender, race/ethnicity, era of military service, and diagnoses (e.g., PTSD). Lastly, study personnel will interview 15 women with AUD who were eligible but did not enroll in the RCT to understand their perceptions of the program and barriers to participation.

The CFIR framework will be used to guide the interview approach. CFIR is a typology of 39 constructs from five main domains that identify factors associated with successful implementation and maintenance of health care innovations: (1) Intervention Characteristics; (2) Inner Setting; (3) Outer Setting; Characteristics of Individuals; (5) Process. If Aim 1 hypotheses are supported, these interviews will help guide subsequent implementation trials of FS-CBT by explaining: (a) barriers and facilitators to participation; perceptions about why FS-CBT is successful at achieving better outcomes for women Veterans with AUD; the barriers and facilitators to high fidelity implementation of FS-CBT; and the sustainability of FS-CBT in the absence of a funded research project and how to achieve this goal; and (b) how FS-CBT should be adjusted to appeal to the subgroup of Veterans. If Aim 1 hypotheses are not supported, the interviews will determine the reasons why (i.e., questions posed to staff and patients will solicit information on barriers associated with delivery of FS-CBT during the RCT, and what modifications to FS-CBT could be made to maximize effectiveness).

Being tested
Female-Specific Cognitive Behavioral Therapy (FS-CBT), Usual Care
Medical subject headings
Alcoholism, Health Risk Behaviors

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Female-Specific Cognitive Behavioral Therapy (FS-CBT)Behavioural

    FS-CBT is a unique 12-session weekly group CBT treatment designed for women Veterans with AUD and/or risky drinking, and provides (1) AUD interventions, (2) general female-specific content, (3) female-Veteran content, (4) wellness and self-care, and (5) a novel 24/7 social support for abstinence discussion mobile app.

  • Usual CareBehavioural

    Usual care means that participants will receive brief alcohol counseling and have access to available treatments for AUD at the VA.

Study groups in NCT06118346
Study groupRoleWhat they receive
Female-Specific Cognitive Behavioral TherapyExperimentalParticipants in this arm will receive female-specific cognitive behavioral therapy and usual VA care for alcohol use disorder.
Receives: Behavioral: Female-Specific Cognitive Behavioral Therapy (FS-CBT); Behavioral: Usual Care
Usual CareActive comparatorParticipants in this arm will receive usual VA care for alcohol use disorder.
Receives: Behavioral: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alcohol Use Disorders Identification Test (AUDIT)

    10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  2. Structured Clinical Interview for DSM Disorders (SCID) Alcohol Use Disorder Module

    semi-structured interview that assesses for alcohol use disorder based on the Diagnostic and Statistical Manual for Mental Disorders (DSM)

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  3. Form 90 Timeline Followback (TLFB)

    interview used to assess alcohol and drug use over a specific period of time

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  4. Treatment Services Review (TSR)

    interview used to assess use of Veterans Affairs and non-Veterans Affairs treatments including Alcohol Use Disorder treatment, physical and mental health treatment, and use of medications

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  5. Electronic Medical Record (EMR)

    patient's medical records - review to assess use of Veterans Affairs and non-Veterans Affairs treatments including Alcohol Use Disorder treatment, physical and mental health treatment, and use of medications

    Measured: assessed from baseline to 15-months post-baseline follow-up

Secondary outcomes (8)
  1. Outcome Questionnaire-45

    self-report questionnaire used to rate symptoms, interpersonal problems, and social role dysfunction

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  2. Posttraumatic Stress Disorder Checklist (PCL)-5 with Life Events Checklist (LEC)-5

    combined self-report questionnaire and interview used to measure posttraumatic stress disorder symptoms

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  3. Difficulties in Emotion Regulation Scale (DERS)

    self-report questionnaire that assesses emotion regulation

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  4. Coping Strategies Scale (CSS)

    self-report questionnaire used to assess use of coping strategies

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  5. Important People Interview (IPI)

    interview used to assess social network characteristics

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  6. Sociotropy Autonomy Scale (SAS)

    self-report questionnaire used to assess the two personality dimensions of sociotropy and autonomy

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

  7. Use of Women2Women mobile application

    tracking use of mobile app designed to allow participants randomized to the FS-CBT (female-specific cognitive behavioral therapy) + UC (usual care) to interact with and provide support to one another

    Measured: assessed from baseline to 15-months post-baseline follow-up

  8. Self-Care Questionnaire

    self-report questionnaire used to assess level of self-care

    Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2023
  2. Study start24 Feb 2023
  3. Primary completion15 Jun 2026
  4. Study completion30 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
162 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06118346
Sponsor's protocol ID
H00021304
Other IDs
1R01AA028240-01A1
Status last verified
May 2026
First submitted
31 May 2023
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Female-Specific Cognitive Behavioral Therapy (FS-CBT) in people with Alcohol Use Disorder and Risky Health Behavior, run by University of Massachusetts, Worcester at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alcohol Use Disorders Identification Test (AUDIT) (time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in